Company
Epidarex Capital CP, LLP
Official record Companies House · updated 27th September 2026 · Sources
Network
The large node is Epidarex Capital CP, LLP. Red nodes are organisations, white nodes are people. Sign in free to explore further.
Who leads it
- Matthew James MiessauLlp-member · since 2018
- Tracy WeightmanLlp-member · since 2017
- Dr Mary Eugenie CanningLlp-member · since 2017
- Dr Peter Michael FinanLlp-member · since 2017
- Dr Elizabeth Ann RoperLlp-member · since 2013
- Kyparissia Katie SirinakisLlp-designated-member · since 2012
- Andrew Sinclair DunlopLlp-designated-member · since 2012
Directors and secretaries as filed at Companies House.
Do you help lead this organisation? Set up its network · How it works
About
- Incorporated
- 30/11/2012
Ownership
Owned by (2) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.
- Elizabeth Ann Roper
25-50% voting (LLP), 25-50% surplus assets (LLP) · notified 2016-04-06 - Kyparissia Katie Sirinakis
25-50% voting (LLP), 25-50% surplus assets (LLP) · notified 2016-04-06 - Possible match - name could not be confirmed to one individualiPossible matchThis PSC filing could not be confirmed to one individual. Not shown as confirmed ownership.
Group
- Epidarex Capital CP, LLP
is controlled by Elizabeth Ann Roper
Evidence
active 25-50% voting (LLP), 25-50% surplus assets (LLP) · notified 2016-04-06 · source: Companies House PSC register
Ultimately controlled by Elizabeth Ann Roper.
13 other companies in this group
- Epidarex Capital FP, LLP
- Epidarex Exeed Limited
- Epidarex Capital III UK GP, LP
- Adorx Therapeutics Limited
- Epidarex Capital Partners Limited
- Epidarex Capital II GP, LP
- Lunac Therapeutics Limited
- Macomics LTD
- Rinn Therapeutics Limited
- Clyde Biosciences Limited
- EPX II CO-Invest LP
- Epidarex Capital UK GP, LLP
- Epidarex Capital III UK, LP
Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.
Board analysis
Board DNA
How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current designated members only, past designated members excluded.
2 designated members on the board
- Kyparissia Katie Sirinakis Llp-designated-member · appointed 2012
- Andrew Sinclair Dunlop Llp-designated-member · appointed 2012
Designated members past 6 years
- Kyparissia Katie Sirinakis Llp-designated-member · appointed 2012
- Andrew Sinclair Dunlop Llp-designated-member · appointed 2012
First-time vs portfolio designated members
Portfolio (2)
- Kyparissia Katie Sirinakis Llp-designated-member · appointed 2012
- Andrew Sinclair Dunlop Llp-designated-member · appointed 2012
Where else this board sits iWhere else this board sitsThe charitable fields these designated members govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.
The sectors these designated members govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.
Gaps to watch
- Several long-serving directors could step down together
Where to look Suggested search: succession planning for long-tenured seats.
Sources
Official record from Companies House. Governance Register calculates the connections.
Record details
- Company number
- SO304176
- Status
- Active
- Type
- Limited Liability Partnership
- Edition
- Register edition compiled 27th September 2026
- Labels
- Official record from Companies House · Calculated derived by Governance Register.
Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data